Evidence map›Paper›PMID 41799566›Full record

ArticlePathology oncology research : POR2026

Germline

Aliz Nikolényi, Ágnes Dobi, Dóra Sántha, Renáta Kószó, Máté Iványi, Emese Horváth, Márton Zsolt Enyedi, Katalin Priskin, Bernadett Csányi, Attila Patócs and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Reclassification ofCurrent oncology (Toronto, Ont.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Aliz NikolényiDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Ágnes DobiDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Dóra SánthaDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Renáta KószóDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Máté IványiDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Emese HorváthDepartment of Medical Genetics, University of Szeged, Szeged, Hungary.
Márton Zsolt EnyediDelta Bio 2000 Ltd., Szeged, Hungary.
Katalin PriskinDelta Bio 2000 Ltd., Szeged, Hungary.
Bernadett CsányiDelta Bio 2000 Ltd., Szeged, Hungary.
Attila PatócsDepartment of Molecular Genetics and The National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, Budapest, Hungary.
Henriett ButzDepartment of Molecular Genetics and The National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, Budapest, Hungary.
János PappDepartment of Molecular Genetics and The National Tumour Biology Laboratory, National Institute of Oncology, Comprehensive Cancer Centre, Budapest, Hungary.
Zoltán VargaDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Rozália TóthDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Judit OláhDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.
Zsuzsanna KahánDepartment of Oncotherapy, University of Szeged, Szeged, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of

Indexed as

Biomarkers, TumorBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsGenetic TestingGerm-Line MutationAdultAgedFemaleGenetic Predisposition to DiseaseHumansMiddle AgedPrognosisRetrospective StudiesBiomarkers, TumorBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanBRCA1/2breast cancercancer susceptibility genesgermline testingmedical genetics

Identifiers

PMID41799566
PMCPMC12963016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.